Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Sunday, September 6
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Investing»FTSE 100 today: Stocks rise as soft U.S. retail data trims Fed rate bets By Investing.com
    Investing

    FTSE 100 today: Stocks rise as soft U.S. retail data trims Fed rate bets By Investing.com

    August 17, 20263 Mins Read


    Investing.com — British stocks edged higher on Monday as a sharper-than-expected fall in U.S. retail sales reduced expectations for near-term Federal Reserve tightening, helping London blue chips claw back ground after losing 1.4% last week.

    The FTSE 100 rose 0.26% as of 03:25 ET (07:25 GMT). Germany’s DAX slipped by 0.03% while France’s CAC 40 inched lower 0.05%. Sterling firmed 0.22% to $1.3562.

    U.S. retail sales fell 0.6% month-on-month in July, sharply missing expectations of a 0.1% rise and marking the steepest monthly decline since May 2025, pushing Treasury yields and the dollar lower on Friday and improving sentiment heading into Monday’s session.

    Speaking at Market Regulation Headquarters on Sunday evening, Iran’s vice president said Tehran would be successful in its “economic warfare” as Washington anticipated an announcement of fresh sanctions this week.

    Ship-tracking firm Kpler recorded no commodity vessel crossings of the Strait of Hormuz on Sunday and just five on Saturday, against 31 the previous weekend.

    The 60-day U.S.-Iran memorandum of understanding, signed in June to halt hostilities, expired Monday with no extension talks under way; Tehran has said Washington must first honour its original obligations.

    The Mecca Joint Defence Agreement, signed Aug. 7 by Saudi Arabia, Turkiye and Pakistan, establishing collective-defence provisions, drew a welcoming statement from Washington; Turkish President Erdogan said the pact had “sent an important message to the world” and called Egyptian participation “possible.”

    Analysts at Jefferies said Monday they saw no straightforward resolution to the standoff, describing the situation as “no war and no peace” with the Strait of Hormuz closed.

    “The only possibility remains a fudge or look the other way arrangement by which some traffic can start to flow through the Strait while the US and Iran try to negotiate a deal,” strategist Mohit Kumar wrote in a morning note.

    Jefferies warned the uneasy truce may hold only through the U.S. mid-term elections, after which the risk of escalation rises, and said from a market perspective the critical variable was how high oil prices climb before Washington is prepared to offer concessions.

    The broker added that Asia and Europe were more exposed than the United States to a prolonged Hormuz disruption given their heavier reliance on imported energy.

    UK housing data compounded a cautious domestic picture. Asking prices fell 2% month-on-month in August to an average £364,999, the largest August drop since 2018 and the sharpest annual decline, down 1% year-on-year, since December 2023, according to a media report citing Rightmove data. Available homes for sale hit a 12-year seasonal high.

    Rightmove downgraded its full-year 2026 price forecast to between 0% and minus 2%, from a prior projection of plus 2%. “The mini Burnham bounce and some renewed general optimism have brought a degree of improvement,” Rightmove’s Colleen Babcock was quoted as saying, “but whether that develops into a more sustained recovery will likely depend on confidence, mortgage rates and the new chancellor’s first budget this Autumn.”

    Brent crude slipped 0.30% to $88.26 a barrel and WTI fell 0.70% to $80.90. Gold futures rose 0.36% to $4,453.35 an ounce; spot gold gained 0.46% to $4,397.18.

    UK round up

    AstraZeneca discontinued the Phase III eVOLVE-Lung02 trial after an independent review found volrustomig plus chemotherapy was unlikely to meet its progression-free or overall survival endpoints versus pembrolizumab plus chemotherapy.

    The trial enrolled 895 patients, with no new safety signals identified; other Phase III volrustomig trials will continue as planned.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleBitcoin ETFs record largest outflow in six weeks as token stagnates | Cryptocurrency
    Next Article Bitcoin Price Prediction 2026: Why BTC Is Stuck Near $63,000

    Related Posts

    Investing

    Europe’s satellite launch ambitions take off as German rocket reaches orbit By Investing.com

    September 5, 2026
    Investing

    Jefferies identifies three scenarios that could drive gold above $5,000 By Investing.com

    September 5, 2026
    Investing

    Global macro outlook: Hormuz, Fed hike odds, and the bond rout — week of September 4, 2026 By Investing.com

    September 4, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Investing

    USD/JPY Outlook: Testing the MoF Zone as Intervention Risk Intensifies

    May 4, 2026
    Bitcoin

    L’été calme du Bitcoin cache un signal haussier à long terme

    June 30, 2025
    Bitcoin

    Bitcoin Price Prediction: Can BTC Break $81K Resistance?

    August 28, 2026
    What's Hot

    Latest Market News Today Live Updates July 15, 2024: Sebi to release discussion paper on curbing retail speculation in equity futures and options trading

    July 15, 2024

    13 Ways Retirees Can Save Money on Utilities This Summer

    July 21, 2024

    Bitcoin Funding Hits 2-week High: Are Bulls Back?

    June 22, 2026
    Most Popular

    Indonesia removes finance minister Sri Mulyani after protests

    September 8, 2025

    Memory giants are returning billions to shareholders. Could Micron follow? By Investing.com

    August 20, 2026

    As BTC, ETH prices gain, derivatives signal skepticism over a sustained rally

    June 22, 2026
    Editor's Picks

    Sharper Shape bolsters utility inspection offering with AI-powered Asset Insights for automated component identification and defect detection

    October 10, 2024

    Bitcoin Price to Hit $1.3M by 2035, Says Crypto Asset Manager Bitwise

    August 22, 2025

    Stock market today: Asian shares are mostly lower after tech-fueled gain on Wall Street

    March 23, 2025
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.